| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.2 | 0.0003 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.2 | 0.0006 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.096 | 0.003 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.004 |